Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Cell Stem Cell|November 10, 2009
FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasisJi-hye Paik, Zhihu Ding, Rujuta Narurkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling InhibitionJohn D Martin, Ryan M Lanning, Vikash P Chauhan, et al.
Psychology, Health & Medicine|July 14, 2011
Testing the effects of an expectancy-based intervention among adolescents: Can placebos be used to enhance physical health?Mark R Beauchamp, Ryan E Rhodes, Silvia Hua, et al.
Annales De Cardiologie Et D'Angeiologie|November 9, 2015
[Management of patients treated for acute ST-elevation myocardial infarction in Tunisia: Preliminary results of FAST-MI Tunisia Registry from Tunisian Society of Cardiology and Cardiovascular Surgery]F Addad, J Gouider, E Boughzela, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 26, 2024
Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbitsMeenal Datta, Laura E Via, Véronique Dartois, et al.
Cureus|September 11, 2024
Thin Skin in Rhinoplasty: Considerations for Camouflaging Dorsal Nasal IrregularitiesReda M Daoud, Abdulrahman A Alelyani, Basel H Bakhamees, et al.
Nature Nanotechnology|July 13, 2023
Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticlesPere Dosta, Alexander M Cryer, Michelle Z Dion, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophagesTeresa E Peterson, Nathaniel D Kirkpatrick, Yuhui Huang, et al.
The Oncologist|April 13, 2019
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung CancerLecia V Sequist, Jhanelle Elaine Gray, Wael A Harb, et al.
Nature Biomedical Engineering|April 7, 2019
Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse modelsWalid S Kamoun, Dmitri B Kirpotin, Zhaohua Richard Huang, et al.
Pageof 15